PROTECT Drugs Tied to Slower eGFR Decline vs Standard Care in IgA Nephropathy

Slower kidney function decline observed with sparsentan and irbesartan

Related Keywords

New York ,United States ,Chee Kay Cheung ,National Kidney Foundation Spring Clinical ,National Kidney Foundation ,Rare Kidney Diseases ,Leicester General Hospital ,New York City ,United Kingdom Radar Iga ,